Group One Trading’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,900
| Closed | -$149K | – | 8283 |
|
|
2022
Q4 | $149K | Buy |
6,900
+3,100
| +82% | +$65.5K | ﹤0.01% | 4099 |
|
|
2022
Q3 | $74K | Hold |
3,800
| – | – | ﹤0.01% | 5067 |
|
|
2022
Q2 | $75K | Buy |
+3,800
| New | +$100K | ﹤0.01% | 5235 |
|
|
2022
Q1 | – | Sell |
-5,000
| Closed | -$116K | – | 9023 |
|
|
2021
Q4 | $116K | Sell |
5,000
-13,100
| -72% | -$348K | ﹤0.01% | 5605 |
|
|
2021
Q3 | $565K | Sell |
18,100
-20,700
| -53% | -$640K | ﹤0.01% | 4047 |
|
|
2021
Q2 | $1.36M | Hold |
38,800
| – | – | ﹤0.01% | 3059 |
|
|
2021
Q1 | $1.37M | Sell |
38,800
-30,600
| -44% | -$1.13M | ﹤0.01% | 2874 |
|
|
2020
Q4 | $2.6M | Sell |
69,400
-44,500
| -39% | -$1.62M | ﹤0.01% | 1820 |
|
|
2020
Q3 | $3.8M | Buy |
+113,900
| New | +$3.32M | 0.01% | 1099 |
|
|
2015
Q3 | – | Sell |
-67
| Closed | -$2K | – | 5307 |
|
|
2015
Q2 | $2K | Hold |
67
| – | – | ﹤0.01% | 4695 |
|
|
2015
Q1 | $2K | Sell |
67
-473
| -88% | -$19.9K | ﹤0.01% | 4586 |
|
|
2014
Q4 | $22K | Sell |
540
-27
| -5% | -$1.19K | ﹤0.01% | 3900 |
|
|
2014
Q3 | $28K | Buy |
567
+267
| +89% | +$15.3K | ﹤0.01% | 3923 |
|
|
2014
Q2 | $19K | Sell |
300
-1,790
| -86% | -$124K | ﹤0.01% | 4199 |
|
|
2014
Q1 | $171K | Sell |
2,090
-260
| -11% | -$23.7K | ﹤0.01% | 2573 |
|
|
2013
Q4 | $161K | Sell |
2,350
-4,053
| -63% | -$297K | ﹤0.01% | 2623 |
|
|
2013
Q3 | $605K | Buy |
6,403
+5,190
| +428% | +$676K | 0.01% | 1449 |
|
|
2013
Q2 | $152K | Buy |
+1,213
| New | +$126K | ﹤0.01% | 2419 |
|
Other funds holding ALBO
Group One Trading's ALBO Position: Q1 2023 in Review
Group One Trading sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 773 shares — an estimated $16.7K sold.
Group One Trading first reported a position in ALBO in Q2 2013 and held it in 32 quarters. The position peaked at $1.27M in Q3 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.
- Group One Trading reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
- Group One Trading sold 773 Albireo Pharma Inc shares in Q1 2023, an estimated $16.7K.
- Group One Trading first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 32 quarters.
- Group One Trading's Albireo Pharma Inc position peaked at $1.27M in Q3 2020.
- 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.
Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.